Distinct metabolic profile of primary focal segmental glomerulosclerosis revealed by NMR-based metabolomics.
Distinct metabolic profile of primary focal segmental glomerulosclerosis revealed by NMR-based metabolomics.
复制标题
基于 NMR 的代谢组学揭示了原发性局灶节段性肾小球硬化的独特代谢特征
DOI:
10.1371/journal.pone.0078531
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Chen N
中科院分区:
文献类型:
--
作者:
Hao X;Liu X;Wang W;Ren H;Xie J;Shen P;Lin D;Chen N
Background Primary focal segmental glomerulosclerosis (FSGS) is pathological entity which is characterized by idiopathic steroid-resistant nephrotic syndrome (SRNS) and progression to end-stage renal disease (ESRD) in the majority of affected individuals. Currently, there is no practical noninvasive technique to predict different pathological types of glomerulopathies. In this study, the role of urinary metabolomics in the diagnosis and pathogenesis of FSGS was investigated. Methods NMR-based metabolomics was applied for the urinary metabolic profile in the patients with FSGS (n = 25), membranous nephropathy (MN, n = 24), minimal change disease (MCD, n = 14) and IgA nephropathy (IgAN, n = 26), and healthy controls (CON, n = 35). The acquired data were analyzed using principal component analysis (PCA) followed by orthogonal projections to latent structure discriminant analysis (OPLS-DA). Model validity was verified using permutation tests. Results FSGS patients were clearly distinguished from healthy controls and other three types of glomerulopathies with good sensitivity and specificity based on their global urinary metabolic profiles. In FSGS patients, urinary levels of glucose, dimethylamine and trimethylamine increased compared with healthy controls, while pyruvate, valine, hippurate, isoleucine, phenylacetylglycine, citrate, tyrosine, 3-methylhistidine and β-hydroxyisovalerate decreased. Additionally, FSGS patients had lower urine N-methylnicotinamide levels compared with other glomerulopathies. Conclusions NMR-based metabonomic approach is amenable for the noninvasive diagnosis and differential diagnosis of FSGS as well as other glomerulopathies, and it could indicate the possible mechanisms of primary FSGS.
登录
查看更多内容
影响因子:
4.4
作者:
Mao, Hailei;Wang, Huimin;Lin, Donghai
通讯作者:
Lin, Donghai
影响因子:
9.8
作者:
LONG, CL;HAVERBERG, LN;GEIGER, JW
通讯作者:
GEIGER, JW
DOI:
10.1158/1055-9965.epi-11-0048
发表时间:
2011-06
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
Cross AJ;Major JM;Sinha R
通讯作者:
Sinha R
影响因子:
3.7
作者:
Li M;Song Y;Cho N;Chang JM;Koo HR;Yi A;Kim H;Park S;Moon WK
通讯作者:
Moon WK
影响因子:
2.5
作者:
MAIZA, A;WALDEK, S;DALEYYATES, PT
通讯作者:
DALEYYATES, PT